Physician

Heema Kaul, M.D.

According to 2025 Medicare claims, Heema Kaul, M.D. (NPI: 1891961736) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Essex, MA. This provider's primary affiliated billing organization is TALLMAN EYE ASSOCIATES, PC (NPI: 1194833467; TIN: 04-2624483) and primary practice location at 01843-1764. Kaul is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Kaul's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 13,632 HCPCS/CPT codes, and received $1,021,117 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 65 prescription claims across 38 beneficiaries totaling $2,770 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). Open Payments data shows 7 records totaling $424. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $241,911 to $1,021,117. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,213 and ending at $2,770. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$609K$1.2M2015 Medicare payment: $241,911 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $605,704 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $668,258 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $841,059 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,059,419 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,007,945 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,218,018 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,160,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,167,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,021,117 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156342,351$241,911
20167284,182$605,704
20177414,385$668,258
20188965,223$841,059
20198225,139$1,059,419
20205874,278$1,007,945
20215484,897$1,218,018
20225124,568$1,160,792
20235635,396$1,167,740
202455913,632$1,021,117

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$28K2015 Drug cost: $10,213 (USD; Tot_Drug_Cst)2016 Drug cost: $12,736 (USD; Tot_Drug_Cst)2017 Drug cost: $16,614 (USD; Tot_Drug_Cst)2018 Drug cost: $27,435 (USD; Tot_Drug_Cst)2019 Drug cost: $27,538 (USD; Tot_Drug_Cst)2020 Drug cost: $12,057 (USD; Tot_Drug_Cst)2021 Drug cost: $27,348 (USD; Tot_Drug_Cst)2022 Drug cost: $11,753 (USD; Tot_Drug_Cst)2023 Drug cost: $6,737 (USD; Tot_Drug_Cst)2024 Drug cost: $2,770 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201578160$10,213
201666156$12,736
201779184$16,614
201872254$27,435
201970197$27,538
202055126$12,057
202143119$27,348
20222778$11,753
20233471$6,737
20243865$2,770

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg137845$662
92014Established patient complete exam of visual system5281,043$91
67028Injection of drug into eye161619$83
92134Imaging of retina4851,032$31
92250Photography of the retina104123$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14234$158
LatanoprostLatanoprost11497$97

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$424Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Heema Kaul, M.D.?

Tedicare shows public-source Medicare data for Heema Kaul, M.D. (NPI 1891961736), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Heema Kaul, M.D. have ACO affiliation data?

Heema Kaul, M.D. is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Heema Kaul, M.D.?

Heema Kaul, M.D. is linked to TALLMAN EYE ASSOCIATES, PC (billing NPI 1194833467) in the available physician profile data.

Does Heema Kaul, M.D. have Open Payments data?

Heema Kaul, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.